OUTLOOK BUSINESS-VALUE RESEARCH FUND MANAGERS RANKING

Your definitive guide to India's Best Fund Managers

March 02, 2021

“We may see two or four multinational, chemical companies emerging out of India”

Kotak Mahindra's Pankaj Tibrewal on the structural shift in specialty chemicals and why portfolio construction should trump stock picking

N Mahalakshmi - March 01, 2021

Is Castrol India a mispriced deep value bet or just a dividend play?

The lubricants major’s valuation has eroded over fears of volume contraction due to the onset of electric vehicles  

Rajesh Padmashali - January 15, 2021

Why replicating Aditya Puri's iconic leadership could be a tough ask

While HDFC Bank’s culture is one of performance with conservatism, the next couple of years will be defining for India’s most admired bank

N Mahalakshmi - January 01, 2021

Crowning or fading glory: What will the new HDFC Bank chief deliver?

The bank is facing a perception crisis with high-level exits and the RBI stricture, just as the competitive landscape is changing with freshly-minted fintech companies  

V Keshavdev - January 01, 2021

Why, along with OpenAg, UPL needs OpenAc

The agrochemical giant’s operating catchphrase is OpenAg - open agriculture network. What it needs right now is OpenAc - open accounting  

Rajesh Padmashali - December 18, 2020

Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?

Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh

V Keshavdev - December 10, 2020

Quess Corp is facing a tough fiscal but, as the song goes, “time makes you bolder”

 The market leader is facing short-term headwind, but its prudence will come to its rescue  

Anishaa Kumar - September 04, 2020

Is there more upside in store for pharma stocks?

Over the past year, the Nifty Pharma Index has gained 23% while the Nifty has declined by 11% 

June 30, 2020